Increased Expression of Elastolytic Cysteine Proteases, Cathepsins S and K, in the Neointima of Balloon-Injured Rat Carotid Arteries

American Journal of Pathology

Volumn 164, Issue 1, 2004, Pages 243-251

  Cheng, Xian Wu ^a   Kuzuya, Masafumi ^a   Sasaki, Takeshi ^a   Arakawa, Koji ^b   Kanda, Shigeru ^a   Sumi, Daigo ^a   Koike, Teruhiko ^a   Maeda, Keiko ^a   Tamaya Mori, Norika ^a   Shi, Guo Ping ^c   Saito, Noboru ^b   Iguchi, Akihisa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; CATHEPSIN S; CONGO RED; CYSTATIN C; CYSTEINE PROTEINASE; ELASTIN; MESSENGER RNA; CATHEPSIN; CYSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAROTID ARTERY INJURY; CONTROLLED STUDY; ELASTOLYSIS; ENZYME ACTIVITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FOLLOW UP; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RESTENOSIS; VASCULAR SURGERY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; ENZYME INDUCTION; METABOLISM; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANGIOPLASTY, BALLOON; ANIMALS; BLOTTING, WESTERN; CAROTID ARTERY INJURIES; CATHEPSINS; CYSTATINS; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; ELASTIN; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR;

EID: 1542469612     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63114-8     Document Type: Article

References (37)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
2. Reidy MA, Jackson D, Lindner V: Neointimal proliferation: control of vascular smooth muscle cell growth. Vasc Med Res 1992, 3:156-167
3. Clowes AM, Reidy M, Clowes MM: Kinetics of cellular proliferation after arterial injury: smooth muscle growth in the absence of endothelium. Lab Invest 1983, 49:327-333
4. Leake DS, Hornebeck W, Brechemier D, Robert L, Peters TJ: Properties and subcellular localization of elastase-like activities of arterial smooth muscle cells in culture. Biochim Biophys Acta 1983, 761:41-47
5. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D: Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 1997, 17:439-444
6. Jormsjö S, Wuttge DM, Sirsjö A, Whatling C, Hamsten A, Stemme S, Eriksson P: Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002, 161:939-945
7. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994, 75:539-545
8. Zempo N, Kenagy RD, Au YPT, Bendeck M, Clowes MM, Reidy MA, Clowes AM: Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg 1994, 20:209-217
9. Kanda S, Kuzuya M, Ramos MA, Koike T, Yoshino K, Ikeda S, Iguchi A: Matrix metalloproteinase and αvβ3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice. Arterioscler Thromb Vasc Biol 2000, 20:998-1005
10. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW: Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting matrix metalloproteinases 2 and 9. Circulation 1997, 96:3555-3560
11. De Young MB, Tom C, Dichek DA: Plasminogen activitor inhibitor type I increases neointima formation in balloon-injured rat carotid arteries. Circulation 2001, 104:1972-1977
12. Bendeck MP, Irvin C, Reidy MA: Inhibition of matrix metalloproteinase activity inhibits smooth muscle cells migration but not neointimal thickening after arterial injury. Circ Res 1996, 78:38-43
13. Strauss BH, Robinson R, Batchelor WB, Chisholm RJ, Ravi G, Natarajan MK, Logan KA, Mahta SR, Levy DE, Ezrin AM, Keeley FW: In vivo turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res 1996, 79:541-550
14. Cheng L, Mantile G, Pauly R, Nater C, Felici A, Monticone R, Bilato C, Gluzband YA, Crow MT, Stetler-Stevenson W, Capogrossi MC: Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation 1998, 98:2195-2201
15. Kenamasa K, Ishida N, Kato H, Sakamoto S, Nakabayashi T, Otani N, Ishikawa K, Katori R: Recombinant tissue plasminogen activator prevents intimal hyperplasia after balloon angioplasty in hypercholesterolemic rabbits. Jpn Circ J 1996, 60:889-894
16. Chapman HA, Riese RJ, Shi GP: Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997, 59:63-88
17. Xin XQ, Gunesekera B, Mason RW: The specificity and elastinolytic activities of bovine cathepsin S and H. Arch Biochem Biophys 1992, 299:334-339
18. Bromme D, Bonneau PR, Lachance P, Wiederanders B, Kirschke H, Peters C, Thomas DY, Storer AC, Verner T: Functional expression of human cathepsin S in Saccharomyces cerevisiae: purification and characterization of the recombinant enzyme. J Biol Chem 1993, 268:4832-4838
19. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, Mcnulty DE, Drake FH, Gowen M, Levy MA: Proteolytic activity of human osteoclast cathepsin K. J Biol Chem 1996, 271:12517-12524
20. Kafienah W, Bromme D, Buttle DJ, Croucher LJ, Hollander AP: Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998, 331:727-732
21. Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA: Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem 1992, 267:7258-7262
22. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P: Expression of the elastolytic cathepsin S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998, 102:576-583
23. Miller BF, Kothari HV: Increased activity of lysosomal enzymes in human atherosclerotic aortas. Exp Mol Pathol 1969, 10:288-294
24. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP: Deficiency of cathepsin S reduces athrosclerosis in low-density lipoprotein receptor-deficient mice. J Clin Invest 2003, 111:897-906
25. Abrahamson M, Barrett AJ, Salvesen G, Grubb A: Isolation of six cysteine proteinase inhibitor from human urine. J Biol Chem 1986, 261:11282-11289
26. Barrett AJ, Davies ME, Grubb A: The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun 1984, 120:631-636
27. Brömme D, Rinne R, Kirschke H: Tight-binding inhibition of cathepsin S by cystatins. Biomed Biochim Acta 1991, 50:631-635
28. Petanceska S, Devi L: Sequence analysis, tissue distribution, and expression of rat cathepsin S. J Biol Chem 1992, 267:26038-26043
29. Tanaka S, Tamura K, Mizuno Y: Clinical consideration with special reference to autopsy cases of malignant tumor in the oral cavity, treated with bleomycin (author's translation). Hiroshima Daigaku Shigaku Zasshi 1975, 8:168-175
30. Koji T, Brenner RM: Localization of estrogen receptor messenger ribonucleic acid in rhesus monkey uterus by non-radioactive in situ hybridization with digoxigenin-labeled oligodeoxynucleotides. Endocrinology 1993, 132:382-392
31. Koike T, Kuzuya M, Asai T, Kanda S, Cheng XW, Watanabe K, Banno Y, Nozawa Y, Iguchi A: Activation of MMP-2 by Clostridium difficile toxin B in bovine smooth muscle cells. Biochem Biophys Res Commun 2000, 277:43-46
32. Fujie K, Shinguh Y, Yamazaki A, Hatanaka H, Okamoto M, Okuhara M: Inhibition of elastase-induced acute inflammation and pulmonary emphysema in hamsters by a novel neutrophil elastase inhibitor FR901277. Inflamm Res 1999, 48:160-167
33. Menter JM, Cornelison LM, Cannick L, Patta AM, Dowdy JC, Sayre RM, Abukhalaf IK, Silvestrov NS, Willis I: Effect of UV on the susceptibility of acid-soluble Skh-1 hairless mouse collagen to collagenase. Photodermatol Photoimmunol Photomed 2003, 19:28-34
34. Shi GP, Webb AC, Foster KE, Knoll JHM, Lemere CA, Munger JS, Chapman HA: Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J Biol Chem 1994, 369:11530-11536
35. Gelb BD, Shi GP, Chapman HA, Desnick RJ: Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996, 273:1236-1238
36. Olafsson I: The human cystatin C gene promoter: functional analysis and identification of heterogeneous mRNA. Scand J Clin Lab Invest 1995, 55:597-607
37. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999, 104:1191-1197